Here are seven things to know about the transaction.
1. The transaction was private, and financial terms were not revealed.
2. Navicure, based in Duluth, Ga., will continue to be led by current CEO and founder, James M. Denny Jr., and his executive team. They will retain a meaningful interest in the business.
3. Selling shareholders include JMI Equity and other minority investors.
4. Mr. Denny said of the partnership. “We believe the resources and experience of Bain Capital Private Equity give us an important advantage as we continue to grow our business and deliver an even wider array of differentiated solutions to our clients.”
5. The transaction is expected to close next month.
6. For Navicure, Aeris Partners served as the exclusive M&A advisor, and Jenner & Block acted as legal counsel. Ropes & Gray is serving as legal counsel, and PwC is serving as accounting advisor to Bain Capital Private Equity.
7. Committed financing for the transaction is being provided by Antares Capital serving as administrative agent and lead arranger, and Bain Capital Credit, Capital One Healthcare and NXT Capital serving as joint lead arrangers.
More finance and revenue cycle management:
Louisiana House committee OKs loan from taxpayers to help with hospital funding
Fitch affirms LifePoint Health’s ratings
Brigham spent millions preparing for nurses’ strike
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
